A recent study reveals that patients who come off blockbuster GLP-1 drugs like semaglutide or tirzepatide can put back on lost weight far faster than those who end traditional lifestyle plans.
Published data in a prominent health publication demonstrates that while obese individuals frequently drop a large proportion of their total mass while on the medication, the weight comes back at an estimated rate of 0.8 kg per month upon discontinuation.
"Individuals buying these medications should be cognizant of the danger of fast weight regain when the medication concludes," cautioned researcher Dr. Susan Jebb.
This pace of regain implies a reversion to pre-treatment weight in about 18 months.
Analyzing Approaches
The analysis, which looked at 37 of studies involving over 9,000 of participants, contrasted the effects of GLP-1 agonists with conventional dieting.
Researchers point out that people who shed pounds through diet and exercise usually experience a slower creep back—approximately 0.1 kg a month—once they finish.
The Reason for the Rapid Rebound
Experts propose the mode of action of the jabs accounts for the amplified rebound.
These medications copy a body's own chemical called glucagon-like peptide-1, which helps regulate appetite.
"Sustained high doses of GLP-1 levels several times higher than the body's typical production may cause the system to generate a reduced amount of its own natural GLP-1, and may also lessen responsiveness to its actions," explained Dr. Adam Collins, a nutrition specialist.
"Withdrawal of this hormone supplement leads to hunger is uncontrolled, making overeating much more probable."
A Chronic Condition?
Medical guidelines suggest the jabs for people with weight-linked medical conditions, accompanied by recommended diet and exercise modifications.
Professionals contend that, due to the significant potential of relapse, the therapy might need to be ongoing.
This perspective is echoed by pharmaceutical companies, who note that the findings "underscore the persistent character of excess weight," comparing it to managing conditions like diabetes.
Patient Testimonies
Users who have stopped the jabs explain a sudden resurgence of cravings.
"It was like a trigger that goes on and you become ravenous," described one woman.
The struggle is worsened if users have not established permanent dietary or behavioural changes during treatment.
Growing Use
Recent estimates show that a significant number of people in the UK have tried weight-loss jabs in the past year, with demand remaining high.
- Use is higher among females compared to males.
- The middle-aged demographic shows the highest level of interest.
- Many obtain the medications through private healthcare rather than public health services.
In conclusion, researchers stress that while these medications are powerful agents for weight loss, they are not a standalone solution and lasting health benefits hinges on combined behavioural support.